FEATURED NEWS
NEWS: COVID-19 VACCINE RECEIVES HEALTH CANADA APPROVAL (DEC 2020)
The BioNTech (with Pfizer) COVID-19 vaccine that uses our lipid nanoparticle delivery system technology has received emergency use authorization by Health Canada. Read about it here.
NEWS: COVID-19 VACCINE WITH CUREVAC (NOV 2020)
Biotech firm CureVac is using Acuitas Therapeutics’ lipid nanoparticles as part of their COVID-19 vaccine. CureVac announced positive results in their clinical studies. Read about it here.
NEWS: ACUITAS THERAPEUTICS NAMES NEW FINANCE & OPERATIONS SENIOR DIRECTOR (Apr 2021)
Abi Coman-Walker has joined Acuitas Therapeutics as Senior Director, Finance & Operations. Read about it here.